相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration
All Dirani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
RESPONSE OF PIGMENT EPITHELIAL DETACHMENTS TO INTRAVITREAL AFLIBERCEPT AMONG PATIENTS WITH TREATMENT-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Geoffrey K. Broadhead et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
Alberto Ferreira et al.
PLOS ONE (2015)
Clinical Utilization of Anti-VEGF Agents and Disease Monitoring in Neovascular Age-Related Macular Degeneration
Nancy M. Holekamp et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration
Yiannis Iordanous et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2014)
Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
Allen C. Ho et al.
OPHTHALMOLOGY (2014)
Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration
Stephen S. Johnston et al.
ADVANCES IN THERAPY (2013)
Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
K. H. Patel et al.
EYE (2013)
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Brandon G. Busbee et al.
OPHTHALMOLOGY (2013)
ALTERATIONS OF VASCULAR PIGMENT EPITHELIUM DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION DURING UPLOAD WITH INTRAVITREAL RANIBIZUMAB
Armin Wolf et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
Georgios D. Panos et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Treatment Patterns for Neovascular Age-Related Macular Degeneration: Analysis of 284 380 Medicare Beneficiaries
Lesley H. Curtis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?
David J. Browning et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
Nicholas Papadopoulos et al.
ANGIOGENESIS (2012)
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence
Ugo Introini et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Mechanisms of Age-Related Macular Degeneration
Jayakrishna Ambati et al.
NEURON (2012)
Biological, Preclinical and Clinical Characteristics of Inhibitors of Vascular Endothelial Growth Factors
Victor Chong
OPHTHALMOLOGICA (2012)
Two-Year Course of Subfoveal Pigment Epithelial Detachment in Eyes with Age-Related Macular Degeneration and Visual Acuity Better than 20/40
Takayuki Baba et al.
OPHTHALMOLOGICA (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
TIME TO FIRST TREATMENT The Significance of Early Treatment of Exudative Age-related Macular Degeneration
Renate Rauch et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Anti-VEGF Treatment Strategies for Wet AMD
Jaclyn L. Kovach et al.
JOURNAL OF OPHTHALMOLOGY (2012)
Automated Characterization of Pigment Epithelial Detachment by Optical Coherence Tomography
Sun Young Lee et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Myositis Ossificans
Deborah A. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PROGNOSTIC IMPLICATIONS OF PIGMENT EPITHELIAL DETACHMENT IN BEVACIZUMAB (AVASTIN)-TREATED EYES WITH AGE-RELATED MACULAR DEGENERATION AND CHOROIDAL NEOVASCULARIZATION
William R. Freeman et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Effect of intravitreal ranibizumab in avascular pigment epithelial detachment
M. Ritter et al.
EYE (2010)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown et al.
OPHTHALMOLOGY (2009)
Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration
Florence Coscas et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization
JM Rakic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
分享论文
